Mats Anders Nilsson
Chief Executive Officer bei KARESSA PHARMA HOLDING AB (PUBL)
Profil
Mats Anders Nilsson has worked as a Chief Executive Officer at Karessa Pharma Holding AB since 2018.
Aktive Positionen von Mats Anders Nilsson
| Unternehmen | Position | Beginn |
|---|---|---|
| KARESSA PHARMA HOLDING AB (PUBL) | Chief Executive Officer | 01.01.2018 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Karessa Pharma Holding AB
 Karessa Pharma Holding AB Pharmaceuticals: MajorHealth Technology Karessa Pharma Holding AB engages in the development and commercialization of products in the therapeutic area of erectile dysfunction. Its patented drug is an alignate-based polymer film that is applied to the oral mucosa, which then rapidly delivered out into the bloodstream. The company was founded by Fredrik Hubinette on September 11, 2013 and is headquartered in Taby, Sweden. | Health Technology |
